Seeking Alpha
Profile| Send Message|
( followers)  

Chindex International (ticker: CHDX), an independent American provider of
Western healthcare products and medical services in China, announced Q3 2005 earnings results on February 9th. There were no analyst estimates. Details:


Q3 Results
(all percentage changes and comparisons are year on year, unless stated otherwise)

  • Revenue rose 3.2% to $22.3 million.
  • Healthcare services costs rose 56.2% to $6.8 million.
  • Sales and marketing expenses rose 31.0% to $3.3 million.
  • General and administrative expenses rose 26.9% to $2.0 million.
  • Operating income loss was $3.3 million versus a loss of $521,000.
  • Net loss was $3.7
    million versus a loss of $383,000.
  • EPS loss of $0.69 versus a loss of $0.10.

Revenue Breakdown
(all percentage changes and comparisons are year on year, unless stated otherwise)

  • Healthcare Services rose 14%.
  • Medical Capital Equipment rose 8%.
  • Healthcare Products Distribution declined 7%.

Roberta Lipson, President and CEO

....As previously announced, our results this quarter
were significantly impacted by a variety of factors, the most
significant being expenses related to delays in the opening and the
start-up costs of our new Shanghai United Family Hospital and delays
in the rollout of certain branded products in the retail pharmacy
business. These factors, combined with lower than expected revenue
growth in all divisions, an overall increase in general administrative
expenses, substantially due to the increased costs for corporate
governance requirements, and an increase in our reserve for doubtful
accounts, resulted in the increased operating losses reported for the
period compared to the prior year.

CHDX chart.

Chdx53

Source: Chindex (CHDX) posts loss on increased costs and lower than expected revenue growth (3Q05 earnings)